CDK5 (cyclin dependent kinase 5)

2003-05-01  

Identity

HGNC
LOCATION
7q36.1
LOCUSID
ALIAS
LIS7,PSSALRE
FUSION GENES

Other Information

Locus ID:

NCBI: 1020
MIM: 123831
HGNC: 1774
Ensembl: ENSG00000164885

Variants:

dbSNP: 1020
ClinVar: 1020
TCGA: ENSG00000164885
COSMIC: CDK5

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000164885ENST00000297518Q00535
ENSG00000164885ENST00000297518A0A0S2Z355
ENSG00000164885ENST00000485972Q00535
ENSG00000164885ENST00000485972A0A090N7W4

Expression (GTEx)

0
10
20
30
40
50
60
70
80
90

Pathways

PathwaySourceExternal ID
Axon guidanceKEGGko04360
Alzheimer's diseaseKEGGko05010
Axon guidanceKEGGhsa04360
Alzheimer's diseaseKEGGhsa05010
Cocaine addictionKEGGhsa05030
Cocaine addictionKEGGko05030
DiseaseREACTOMER-HSA-1643685
HemostasisREACTOMER-HSA-109582
Factors involved in megakaryocyte development and platelet productionREACTOMER-HSA-983231
Signal TransductionREACTOMER-HSA-162582
Signaling by GPCRREACTOMER-HSA-372790
Opioid SignallingREACTOMER-HSA-111885
DARPP-32 eventsREACTOMER-HSA-180024
Gene ExpressionREACTOMER-HSA-74160
Generic Transcription PathwayREACTOMER-HSA-212436
Transcriptional Regulation by TP53REACTOMER-HSA-3700989
Developmental BiologyREACTOMER-HSA-1266738
Axon guidanceREACTOMER-HSA-422475
Semaphorin interactionsREACTOMER-HSA-373755
CRMPs in Sema3A signalingREACTOMER-HSA-399956
Regulation of TP53 ActivityREACTOMER-HSA-5633007
Regulation of TP53 Activity through PhosphorylationREACTOMER-HSA-6804756
Neurodegenerative DiseasesREACTOMER-HSA-8863678
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease modelsREACTOMER-HSA-8862803

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA33639PPP1R1BGenePathwayassociated

References

Pubmed IDYearTitleCitations
387428112024miR-4645-3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5.0
387428112024miR-4645-3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5.0
368534852023Comprehensive analysis of CDK5 as a novel biomarker for progression in esophageal cancer.1
369959372023CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth.9
370397462023Higher Levels of Tumour-Infiltrating Lymphocytes (TILs) are Associated with a Better Prognosis, While CDK5 Plays a Different Role Between Nonmetastatic and Metastatic Colonic Carcinoma.2
379762612023Mitigating aberrant Cdk5 activation alleviates mitochondrial defects and motor neuron disease symptoms in spinal muscular atrophy.0
379821422023Activation of cyclin-dependent kinase 5 broadens action potentials in human sensory neurons.1
368534852023Comprehensive analysis of CDK5 as a novel biomarker for progression in esophageal cancer.1
369959372023CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth.9
370397462023Higher Levels of Tumour-Infiltrating Lymphocytes (TILs) are Associated with a Better Prognosis, While CDK5 Plays a Different Role Between Nonmetastatic and Metastatic Colonic Carcinoma.2
379762612023Mitigating aberrant Cdk5 activation alleviates mitochondrial defects and motor neuron disease symptoms in spinal muscular atrophy.0
379821422023Activation of cyclin-dependent kinase 5 broadens action potentials in human sensory neurons.1
347732192022Phosphorylation of CRMP2 by Cdk5 Negatively Regulates the Surface Delivery and Synaptic Function of AMPA Receptors.2
348754512022MiR-142-5p directly targets cyclin-dependent kinase 5-mediated upregulation of the inflammatory process in acquired middle ear cholesteatoma.4
351430522022Cyclin-dependent kinase 5 promotes the growth of tongue squamous cell carcinoma through the microRNA 513c-5p/cell division cycle 25B pathway and is associated with a poor prognosis.3

Citation

Dessen P

CDK5 (cyclin dependent kinase 5)

Atlas Genet Cytogenet Oncol Haematol. 2003-05-01

Online version: http://atlasgeneticsoncology.org/gene/40033/favicon/img/logo-atlas-4.svg